Gene-set enrichment showed that this sharp induction occurred against a background of suppressed adipogenesis and oxidative-phosphorylation programs, suggesting that VAT responds to tumor burden by shifting away from energy-storage genes and strongly favoring omentin expression. The gene discussed is ITLN1; the disease is neoplasm.